Dangers of Off-Label Drug Use
Posted in Drug & Medical Devices on March 20, 2015
We recently reported on the possible dangers of the anti-nausea drug Zofran® and equivalent generics when they are used off-label. But what does “off label” really mean? What is Off-Label Use of Medications? As we explained in an earlier post, “When a drug is used in a way that is different from that described...
Posted in Drug & Medical Devices on March 9, 2015
Zofran® and its generic equivalents have been linked to birth defects and other problems when the medication is taken during pregnancy. The manufacturer, GlaxoSmithKline, promoted the off-label use of the drug as a remedy for morning sickness in addition to its approved use as a drug for controlling nausea and vomiting after chemotherapy and...
Zofran Linked to Birth Defects
Posted in Drug & Medical Devices on March 5, 2015
The anti-nausea drug Zofran® has often been prescribed off-label to pregnant women suffering from serious morning sickness. However, the evidence is growing that taking this drug may cause women to give birth to babies with a variety of birth defects. Zofran was approved in 1991 by the Food and Drug Administration (FDA) for treating...
Side Effects of Anti-Nausea Drug Zofran
Posted in Drug & Medical Devices on February 24, 2015
The drug Zofran® , also known as Ondansetron, is approved by the Food and Drug Administration to treat nausea and vomiting resulting from chemotherapy treatment for cancer and after being administered anesthetic during surgery. The medication works by blocking serotonin, a natural substance in the human body, which can cause vomiting, It is manufactured by...
What is off-label drug use?
Posted in Drug & Medical Devices, Medical Malpractice on July 2, 2013
In the United States before a drug is approved by the Food and Drug Administration (FDA), it must undergo extensive testing. These tests, known as clinical trials, are used to determine if a drug safely works the way it is expected, to treat a specific medical condition. Once the FDA is satisfied that the...